Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating the safety and efficacy of CD33-directed CAR-T cells in relapsed or refractory acute myeloid leukemia. The trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CD33 CAR-T cell

Snippet

Sponsor: Zhejiang University | Conditions: Acute Myeloid Leukemia | EARLY_Phase 1 | Status: RECRUITING